Registry Of Pancreatic Disease

$0.00

Clinical Trial Record

Return to Clinical Trials

Study Start

2016-12-01

Primary Completion (ESTIMATED)

2046-12-01

Study Completion (ESTIMATED)

2046-12-01

Enrollment (ESTIMATED)

3000

Study Overview

Registry of Pancreatic Disease

This clinical data registry records information about the health status and healthcare performances received by participants affected by every type of pancreatic disease or disorder. All data (demographic, clinical, biochemical, radiological, pharmacological, genetic...) and audio and/or video recording from operative room are collected in order to be used for prospective or retrospective studies.

N/A

Pancreatic Diseases
Pancreatic Neoplasms
Pancreatitis

PAD-R 1101CESC

Study Record Dates

These dates track the progress of study record and summary results submissions to ClinicalTrials.gov. Study records and reported results are reviewed by the National Library of Medicine (NLM) to make sure they meet specific quality control standards before being posted on the public website.

Study Registration Dates	Results Reporting Dates	Study Record Updates
First Submitted 2019-01-15	Results First Submitted N/A	Last Update Submitted that met QC Criteria 2019-01-15
First Submitted that Met QC Criteria 2019-01-15	Results First Submitted that Met QC Criteria N/A	Last Update Posted (ACTUAL) 2019-01-17
First Posted (ACTUAL) 2019-01-17	Results First Posted N/A	Last Verified 2019-01

Study Plan

This section provides details of the study plan, including how the study is designed and what the study is measuring.

Design Details

Primary Purpose:
N/A

Allocation:
N/A

Interventional Model:
N/A

Masking:
N/A

Arms and Interventions

Participant Group/Arm	Intervention/Treatment
: Patient with pancreatic disease Patients diagnosed with pancreatic disease evaluated at this institution.

Primary Outcome Measures	Measure Description	Time Frame
Overall survival	Survival from Diagnosis to time of death	1 year

Secondary Outcome Measures	Measure Description	Time Frame
Postoperative morbidity	Occurrence of Pancreatic Fistula, Biliary fistula, Enteric fistula, Delayed Gastric Emptying, Hemorrhage or Sepsis.	90 days

Contacts and Locations

This section provides the contact details for those conducting the study, and information on where this study is being conducted.

Study Contact

Name: Erica Secchettin

Phone Number: +390458126254

Email: erica.secchettin@aovr.veneto.it

Participation Criteria

Researchers look for people who fit a certain description, called eligibility criteria. Some examples of these criteria are a person’s general health condition or prior treatments.

Ages Eligible for Study:
ALL

Sexes Eligible for Study:
18 Years

Accepts Healthy Volunteers:

any type of pancreatic disease: inflammatory and neoplastic (including solid and cystic lesions)

physically or mentally inability to provide consent

Collaborators and Investigators

This is where you will find people and organizations involved with this study.

Investigators

PRINCIPAL_INVESTIGATOR: Claudio Bassi, Prof, AOUI Verona

Publications

The person responsible for entering information about the study voluntarily provides these publications. These may be about anything related to the study.

General Publications

No publications available

Learn

Resources

PatientS

Caregivers

Clinical Trial Record